Authors :
Alshada Sharf; G. Vimal Raj; Thomas Jude Rodriguez; S. Jothi Mani; Dr. Arul Prakasam K
Volume/Issue :
Volume 10 - 2025, Issue 6 - June
Google Scholar :
https://tinyurl.com/mu84xj3w
DOI :
https://doi.org/10.38124/ijisrt/25jun117
Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.
Abstract :
Antiepileptic drugs (AEDs) are the cornerstone of epilepsy management, yet their adverse effects (AEs) often
compromise patient well‐being. These AEs range from mild somatic symptoms to severe psychiatric and cognitive
disturbances, significantly impacting quality of life (QoL) regardless of seizure control. This review compiles current
evidence on the spectrum of AED‐related AEs, their influence on QoL, and the differential profiles of older versus newer
AEDs. It also examines psychosocial outcomes and strategies to mitigate these impacts—insights essential for personalised
treatment planning.
References :
- Perucca P, Gilliam FG. Adverse effects of antiepileptic drugs. Lancet Neurol. 2012;11(9):792‑802.
- Johannessen Landmark C, Patsalos PN. Drug interactions involving the new second‑ and third‑generation AEDs. Expert Rev Neurother. 2010;10(1):119‑40.
- Eddy CM, Rickards HE, Cavanna AE. The cognitive impact of AEDs. Ther Adv Neurol Disord. 2011;4(6):385‑407.
- Mula M, Sander JW. Negative effects of AEDs on mood in epilepsy. Drug Saf. 2007;30(7):555‑67.
- Helmstaedter C, Witt JA. Effects of levetiracetam on cognition. Epilepsy Behav. 2008;13(4):642‑9.
- Hirsch LJ, et al. Cross‑sensitivity of skin rashes with AED use. Neurology. 2008;71(19):1527‑34.
- Baker GA, et al. QoL of people with epilepsy: a European study. Epilepsia. 1997;38(3):353‑62.
- Gilliam F. Optimising health outcomes in active epilepsy. Neurology. 2002;58(Suppl 5):S9‑20.
- Jacoby A. Stigma, epilepsy, and QoL. Epilepsy Behav. 2002;3(6S2):10‑20.
- Brodie MJ, Dichter MA. Antiepileptic drugs. N Engl J Med. 1996;334(3):168‑75.
- Andrew T, et al. Self‑reported AEs of mono‑ and polytherapy for epilepsy. Seizure. 2012;21(8):610‑3.
Antiepileptic drugs (AEDs) are the cornerstone of epilepsy management, yet their adverse effects (AEs) often
compromise patient well‐being. These AEs range from mild somatic symptoms to severe psychiatric and cognitive
disturbances, significantly impacting quality of life (QoL) regardless of seizure control. This review compiles current
evidence on the spectrum of AED‐related AEs, their influence on QoL, and the differential profiles of older versus newer
AEDs. It also examines psychosocial outcomes and strategies to mitigate these impacts—insights essential for personalised
treatment planning.